Brennan, Jr. v. FSD Pharma Inc.

CourtDistrict Court, E.D. Pennsylvania
DecidedDecember 13, 2021
Docket2:21-cv-03771
StatusUnknown

This text of Brennan, Jr. v. FSD Pharma Inc. (Brennan, Jr. v. FSD Pharma Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brennan, Jr. v. FSD Pharma Inc., (E.D. Pa. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

EDWARD BRENNAN, JR. and : HUMA QAMAR : : v. : CIVIL ACTION NO. 21-3771 : FSD PHARMA INC. and : FSD BIOSCIENCES, INC. : :

MCHUGH, J. December 13, 2021 MEMORANDUM This is an action brought against FSD Pharma and its subsidiary, FSD Pharma Inc., following a change in control of the Board and the company’s executive leadership. Plaintiffs Edward Brennan, Jr., and Huma Qamar, two former executives at FSD Pharma, allege that in the months leading up to the proxy fight, FSD Pharma’s CEO entered into oral contracts with Plaintiffs which promised severance payments in the event of a leadership change. Plaintiffs plead that Defendants breached these contractual obligations by failing to provide severance packages following the corporate shake-up. Defendants respond that written contracts govern the parties’ obligations, rendering the alleged oral modifications irrelevant, and therefore move to dismiss for failure to state a claim. As to Ms. Qamar, standard contract principles guide the analysis, and the written agreement she signed, which made no reference to a severance payment, entitles FSD to dismissal of her claims. As to Mr. Brennan, the case presents a complex threshold issue. The written contract between the parties specifies Ontario, Canada as the forum for any dispute. Mr. Brennan contends that this forum selection clause was orally modified in favor of Pennsylvania. The question then arises: should this Court decide whether such a modification occurred, or is that question properly decided by the Canadian court? For this court to presume to answer that question would amount to a premature decision on the merits of a critical issue in the case. I will therefore dismiss Brennan’s claims without prejudice on forum non conveniens grounds, conditioned upon an Ontario court considering his contention that the forum selection clause was orally modified.

I. Factual Allegations This case follows from a proxy fight over leadership of the Board of Directors of FSD Pharma. FSD is a publicly traded holding company and licensed producer of cannabis in Toronto, Canada, with a subsidiary called FSD Biosciences based in Pennsylvania. See Compl. ¶8, ECF 1- 1. In January 2021, a struggle for control of FSD began when some shareholders sought to reduce the size of FSD’s Board of Directors and replace six of the incumbent directors in anticipation of the May 2021 annual meeting. Compl. ¶14, ECF 1. During the shareholder meeting on May 14, 2021, FSD voted to remove FSD’s Chairman and Chief Executive Officer, Raza Bokhari, from the Board. Compl. ¶27, 88. Mr. Bokhari was officially placed on administrative leave on or around May 17, 2021.1 Id. ¶88.

The pending dispute stems from events that took place in the months leading up to the proxy vote. Mr. Brennan and Ms. Qamar allege that, in advance of the vote, Mr. Bokhari entered into binding contracts with them on behalf of FSD specifying that if the proxy vote resulted in a leadership change2 and they resigned or were fired, they would receive severance payments. Id.

1 It is unclear from the pleadings whether Mr. Bokhari was placed on administrative leave on May 14, 2021 or May 17, 2021. Compl. ¶¶27, 88.

2 Defendants argue as an alternative defense that Plaintiffs fail to adequately plead that the leadership change which would trigger the severance payments actually occurred. See Memo in Support of Motion to Dismiss, ECF 15 at 3 (“[T]he Complaint makes clear that Plaintiffs would be entitled to severance if there was a change in the control of FSD Pharma’s board and such a change in Defendants’ executive leadership. But while the Complaint alleges a change in the composition of the board, it does not allege a change in executive leadership. Rather, the Complaint alleges only that Bokhari, FSD Pharma’s CEO, was placed on ¶¶1, 30, 58. Once Bokhari was no longer in charge, Plaintiffs Edward Brennan, Jr. and Huma Qamar, employees of FSD, resigned: Mr. Brennan on June 3, 2002 and Ms. Qamar on May 26, 2021. Id. ¶¶89, 92. They never received their sought-after severance packages, which resulted in their decision to file suit.

The relevant facts are as follows: Plaintiff Edward Brennan, Jr. became the President of FSD Biosciences in May, 2019. Id. ¶17. He worked from Defendants’ office in Bensalem, Pennsylvania. Id. ¶19. His employment was governed by a written contract. Relevant sections of the agreement contain 1) language specifying that modifications to his employment agreement must be in writing, 2) an Ontario choice of law provision, and 3) an Ontario forum selection clause: • Section 7.5 specifies that “[n]o amendment of this Agreement shall be effective unless made in writing and signed by the parties.” Compl. Ex. 2 Employment Agreement, § 7.5. • Section 7.8 specifies that the employment agreement, and any claims arising out

of it, “shall be governed and construed with the laws of the Province of Ontario and the laws of Canada applicable in that Province and shall be treated, in all respects, as an Ontario Contract.” Id. § 7.8. • Section 7.9 specifies as to venue, “[t]he parties agree to attorn to the exclusive jurisdiction of Ontario.” § 7.9. During Brennan’s employment, he became concerned about the brewing proxy fight and whether he should remain employed at FSD and sought assurances from Mr. Bokhari. Id. ¶¶21, 22. In a meeting between Mr. Brennan and Mr. Bokhari on February 7, 2021, Mr. Bokhari

administrative leave.”). I need not reach this issue because even assuming that being placed on administrative leave constituted a leadership change, Plaintiffs’ claims fail. informed Brennan that he would be promoted to Chief Medical Officer (“CMO”) of FSD, his base salary would increase to $350,000, and he would be entitled to severance in the event that there was a change in control of the Board and executive leadership of the company as a result of the proxy fight. Id. ¶¶20-25. Bokhari then informed Donal Carroll, Chief Financial Officer, about the

modifications to Brennan’s employment agreement. Brennan pleads that Bokhari advised Carroll that the venue provision was to be changed to Pennsylvania and instructed Carroll to prepare a written employment agreement memorializing the provisions. Id. ¶¶22, 28-30. Carroll never sent Brennan a modified, written employment contract, but some of the oral modifications – including an increase in pay and a change in job duties as CMO – were implemented by Defendants, during the period in which Bokhari was still employed at the company. Id. ¶¶34, 35. Following the proxy fight, Mr. Brennan resigned from his employment with FSD Biosciences on June 3, 2021, Id. ¶25, but Defendants never paid Brennan the severance payment allegedly owed under the oral agreement with Bokhari. Plaintiff Huma Qamar began working as a Senior Director of FSD Biosciences in late

January 2021. Compl. ¶54. Like Mr. Brennan, she expressed concerns about remaining employed at FSD depending on the outcome of the emerging proxy fight. Id. ¶56. To assuage her concerns, Mr. Bokhari agreed that Ms. Qamar would be promoted to the role of Senior Vice President of FSD and Head of the R&D Program, her base salary would increase to $250,000, and, in the event that the Board and executive leadership changed as a result of the proxy fight, she could elect severance if she was terminated without cause or if she resigned. Id. ¶¶57-59. Bokhari later informed Carroll about the modifications to Qamar’s employment agreement, and he instructed Carroll to prepare a written employment agreement memorializing the provisions that Bokhari and Qamar had agreed upon. Id. ¶¶60, 61. Although Carroll informed Qamar that he was preparing the employment contract with the new terms, Carroll actually provided an employment contract without the inclusion of all the new terms.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Prima Paint Corp. v. Flood & Conklin Mfg. Co.
388 U.S. 395 (Supreme Court, 1967)
Piper Aircraft Co. v. Reyno
454 U.S. 235 (Supreme Court, 1982)
Ruhrgas Ag v. Marathon Oil Co.
526 U.S. 574 (Supreme Court, 1999)
Francis Van Orman, on His Own Behalf and on Behalf of a Class of All Participants, Continuing Former Employees, Pensioners, Beneficiaries and Contingent Survivors, as Such Persons Are Defined in the Revised Retirement Plan of the American Insurance Company, American Automobile Insurance Company and Associated Indemnity Corporation ("Tarp") v. The American Insurance Company, the American Automobile Insurance Company, the Associated Indemnity Corporation, Fireman's Fund Insurance Company, Fireman's Fund American Life Insurance Company, Tarp, and Fireman's Fund American Retirement Plan("farp"), Robert P. J. Cooney and Jack B. McCowan Nellie Taylor, Andrew Marsh, Ulice M. Hoover, Peggy Laing, Richard Shultis and Waldermar Ogren, on Their Own Behalf and on Behalf of All Participants and Beneficiaries Similarly Situated v. The American Insurance Company, the American Automobile Insurance Company, the Associated Indemnity Corporation, Fireman's Fund Insurance Company, Fireman's Fund American Life Insurance Company, Robert P. J. Cooney, Jack B. McCowan and Tarp, Francis Van Orman, on His Own Behalf and on Behalf of All Participants and Beneficiaries Similarly Situated, and Ulice M. Hoover, Nellie Taylor, Peggy Laing, Andrew Marsh, Richard Shultis, and Waldemar H. Ogren, on Behalf of Those and All Other Persons Similarly Situated, in No. 81-2784. The American Insurance Company, the American Automobile Insurance Company, Theassociated Indemnity Corporation, Fireman's Fund Insurance Company,fireman's Fund American Life Insurance Company, Tarp, and Farp, Robert P. j.cooney and Jack b.mccowan and the American Insurance Company, the American Automobile Insurance Company, the Associated Indemnity Corporation, Fireman's Fund Insurance Company, Fireman's Fund American Life Insurance Company, Robert P. J. Cooney, Jack B. McCowan and Tarp, in No. 81-2785 the American Insurance Company, American Automobile Insurance Company, Associated Indemnity Corporation, Fireman's Fund Insurance Company, the Revised Retirement Plan of the American Insurance Company, Fireman's Fund American Retirement Plan, Robert P. J. Cooney and Jack B. McCowan and Fireman's Fund Insurance Company, American Insurance Company, American Automobile Insurance Company, Associated Indemnity Corporation, the Revised Retirement Plan of the American Insurance Company, Associated Indemnity Corporation, Fireman's Fund American Life Insurance Company, Robert P. J. Cooney, and Jack B. McCowan in No. 81-2786
680 F.2d 301 (Third Circuit, 1982)
Harsco Corp. v. Lucjan Zlotnicki
779 F.2d 906 (Third Circuit, 1986)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Revere Press, Inc. v. BLUMBERG
246 A.2d 407 (Supreme Court of Pennsylvania, 1968)
Crouse v. Cyclops Industries
745 A.2d 606 (Supreme Court of Pennsylvania, 2000)
Travers v. Cameron County School District
544 A.2d 547 (Commonwealth Court of Pennsylvania, 1988)
Abbott v. Thomas
286 A.2d 272 (Supreme Court of Vermont, 1971)
Hartley v. United Mine Workers of Am.
113 A.2d 239 (Supreme Court of Pennsylvania, 1955)
Yocca v. Pittsburgh Steelers Sports, Inc.
854 A.2d 425 (Supreme Court of Pennsylvania, 2004)
Porreco v. Porreco
811 A.2d 566 (Supreme Court of Pennsylvania, 2002)
National Auto Brokers Corp. v. Aleeda Development Corp.
364 A.2d 470 (Superior Court of Pennsylvania, 1976)
Moneygram Payment Systems, Inc. v. Consorcio Oriental
65 F. App'x 844 (Third Circuit, 2003)
In Re Howmedica Osteonics Corp.
867 F.3d 390 (Third Circuit, 2017)
Ina Collins v. Mary Kay Inc
874 F.3d 176 (Third Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Brennan, Jr. v. FSD Pharma Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/brennan-jr-v-fsd-pharma-inc-paed-2021.